AptarGroup Non-GAAP EPS of $1.52 beats by $0.05, revenue of $1.02B beats by $39.24M (NYSE:ATR)
AptarGroup reported Q3 Non-GAAP EPS of $1.52, beating estimates by $0.05, with revenue of $1.02B, up 6.1% Y/Y and exceeding expectations by $39.24M. The company forecasts Q4 2026 adjusted EPS between $1.39 and $1.47, above the consensus of $1.41.
How this was made
The 30-second read
Why it matters
The combination of an EPS beat, a revenue beat, and a specific Q4 adjusted EPS range versus consensus is a direct catalyst for near-term valuation and estimates.
Market read
This is a company-specific earnings and guidance update that can drive estimate revisions and short-term positioning.
What to watch
Non-GAAP results can mask underlying margin or restructuring pressures; traders may also focus on whether the revenue beat reflects one-offs versus sustainable volume growth.
Background
The piece summarizes AptarGroup’s Q3 non-GAAP results and provides management’s adjusted EPS outlook for Q4 2026.
Ticker impact
AptarGroup reported Q3 non-GAAP EPS of $1.52 and revenue of $1.02B, both beating estimates, and issued Q4 adjusted EPS guidance of $1.39 to $1.47.
Likely upward pressure as traders price in stronger-than-expected Q3 performance and a Q4 adjusted EPS range that modestly clears consensus.
The article provides concrete Q3 beat figures and a specific Q4 adjusted EPS range with a stated consensus comparison, which are direct inputs to near-term earnings expectations.
Market effects
Supports sentiment for healthcare supply-chain and drug-delivery component names by signaling demand resilience and execution.
Limited direct regional spillover beyond US large-cap healthcare suppliers.
Primarily US-focused read-through; global impact is secondary unless peers react to the guidance signal.
Counterpoint
The guidance range is only slightly above consensus, so the stock may already be positioned for a beat and could fade if margins or cash flow details (not provided here) disappoint.
Key entities
- companyAptarGroup
Reports Q3 non-GAAP EPS and revenue beats and provides Q4 adjusted EPS guidance.
